| Date & Time | 3 June 2026 12:00-13:00 CET |
|---|---|
| Address | Online |
Please save the date for Bridging Nordic ATMP, this season of ATMP Webinar Series hosted by the Nordic EATRIS Nodes. The series will take place online, 12.00-13.00 CET, once a month with a lecture by an expert in the Advanced Therapy Medicinal Products (ATMPs) field. The next edition will feature the following speaker:
Matti Sällberg, Professor at Dept of Lab Medicine, Karolinska Institute, Sweden will be speaking on mRNA/LNP production at the Pre-GMP facility at Karolinska ATMP Centre: domestic mRNA and DNA capabilities for pandemic and crisis preparedness.
Matti Sällberg is a Dr of Dental Surgery (DDS; dentist) by training, holds a PhD in viral immunology, and is a Professor in Biomedical Analysis at Karolinska Institutet, Sweden. He has published over 150 scientific papers and has taken three in-house developed genetic vaccines to phase I clinical trials. The current research focus is on genetic vaccines and gene therapies with direct in vivo delivery of immune genes such as TCRs and antibodies to treat viral infections and cancers.
Register for the webinar here.
Remember to save the dates and look out for updates on each webinar before the start of the event.
The previous events took place on:
- 5 February 2025 – Magnus Essand, Professor of Gene Therapy, Uppsala University, Chief Scientific Officer and co-founder, Elicera Therapeutics
- 12 March 2025 – David Morrow, EATRIS Senior Scientific Programme Manager
- 2 April 2025 – Seppo Ylä-Herttuala, Professor at the University of Eastern Finland
- 7 May 2025 – Kamal Mustafa, Professor at the University of Bergen
- 4 June 2025 – Marie Gårdmark, Co-founder of RegSmart Life Science AB and Anna Pasetto, Director of the Centre for Advanced Cell Therapy (ACT) at Oslo University Hospital
- 3 September 2025 – Janet Hoogstraate, Chief Executive Officer at NorthX Biologics
- 1 October 2025 – Joel Clinton Glover, Director of Norwegian Core Facility for Human Pluripotent Stem Cells at the University of Oslo and Oslo University Hospital.
- 3 November 2025 – Özcan Met, Associate Professor and Head of Cell Therapy Unit, at CCIT-DK and DTU HealthTech
- 3 December 2025 – Erja Kerkelä, Development Manager, Docent (Associate Professor) at the Advanced Cell Therapy Centre, Finnish Red Cross Blood Service.
- 4 February 2026 – Emanuela Oldoni, Scientific Lead Personalised Medicine at EATRIS
- 4 March 2026 – Bjarne Kuno Møller, Dept. of Clinical Immunology, Aarhus University
- 8 April 2026 – Marit Inngjerdingen, Dept. of Pharmacology, University of Oslo, Norway
- 6 May 2026 – Peppi Karppinen, Professor at the University of Oulu, Finland
